Advisors Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.88M | Buy |
13,312
+6,881
| +107% | +$1.32M | 0.04% | 514 |
|
|
2026
Q1 | $1.18M | Buy |
6,431
+219
| +4% | +$40.4K | 0.02% | 750 |
|
|
2025
Q4 | $1.09M | Buy |
6,212
+132
| +2% | +$21.6K | 0.02% | 769 |
|
|
2025
Q3 | $852K | Buy |
6,080
+367
| +6% | +$49.6K | 0.01% | 839 |
|
|
2025
Q2 | $717K | Sell |
5,713
-671
| -11% | -$83.6K | 0.01% | 872 |
|
|
2025
Q1 | $874K | Sell |
6,384
-239
| -4% | -$34.2K | 0.02% | 789 |
|
|
2024
Q4 | $1.01M | Sell |
6,623
-73
| -1% | -$12.3K | 0.02% | 735 |
|
|
2024
Q3 | $1.3M | Buy |
6,696
+147
| +2% | +$30.8K | 0.02% | 676 |
|
|
2024
Q2 | $1.52M | Sell |
6,549
-892
| -12% | -$194K | 0.03% | 617 |
|
|
2024
Q1 | $1.6M | Buy |
7,441
+451
| +6% | +$106K | 0.03% | 617 |
|
|
2023
Q4 | $1.81M | Buy |
6,990
+1,120
| +19% | +$275K | 0.04% | 558 |
|
|
2023
Q3 | $1.51M | Sell |
5,870
-16
| -0.3% | -$4.28K | 0.03% | 586 |
|
|
2023
Q2 | $1.68M | Buy |
5,886
+572
| +11% | +$170K | 0.03% | 573 |
|
|
2023
Q1 | $1.48M | Sell |
5,314
-158
| -3% | -$43.7K | 0.03% | 609 |
|
|
2022
Q4 | $1.52M | Sell |
5,472
-234
| -4% | -$66.1K | 0.03% | 592 |
|
|
2022
Q3 | $1.52M | Buy |
5,706
+335
| +6% | +$71.1K | 0.03% | 578 |
|
|
2022
Q2 | $1.09M | Buy |
5,371
+998
| +23% | +$204K | 0.02% | 732 |
|
|
2022
Q1 | $921K | Sell |
4,373
-911
| -17% | -$198K | 0.01% | 835 |
|
|
2021
Q4 | $1.27M | Buy |
5,284
+236
| +5% | +$60.7K | 0.02% | 765 |
|
|
2021
Q3 | $1.43M | Buy |
5,048
+55
| +1% | +$18K | 0.02% | 707 |
|
|
2021
Q2 | $1.73M | Buy |
4,993
+507
| +11% | +$154K | 0.02% | 638 |
|
|
2021
Q1 | $1.25M | Buy |
4,486
+1,360
| +44% | +$367K | 0.02% | 753 |
|
|
2020
Q4 | $765K | Buy |
3,126
+1,462
| +88% | +$377K | 0.01% | 848 |
|
|
2020
Q3 | $472K | Buy |
1,664
+76
| +5% | +$21.2K | 0.01% | 936 |
|
|
2020
Q2 | $425K | Sell |
1,588
-366
| -19% | -$110K | 0.01% | 945 |
|
|
2020
Q1 | $618K | Sell |
1,954
-488
| -20% | -$148K | 0.01% | 759 |
|
|
2019
Q4 | $725K | Sell |
2,442
-570
| -19% | -$158K | 0.01% | 860 |
|
|
2019
Q3 | $701K | Sell |
3,012
-1,496
| -33% | -$348K | 0.01% | 876 |
|
|
2019
Q2 | $1.05M | Sell |
4,508
-585
| -11% | -$135K | 0.02% | 762 |
|
|
2019
Q1 | $1.2M | Sell |
5,093
-1,287
| -20% | -$405K | 0.02% | 719 |
|
|
2018
Q4 | $1.92M | Sell |
6,380
-7,887
| -55% | -$2.52M | 0.04% | 516 |
|
|
2018
Q3 | $5.04M | Sell |
14,267
-829
| -5% | -$285K | 0.08% | 294 |
|
|
2018
Q2 | $4.38M | Buy |
15,096
+1,115
| +8% | +$313K | 0.07% | 336 |
|
|
2018
Q1 | $4.03M | Buy |
13,981
+179
| +1% | +$55.6K | 0.07% | 385 |
|
|
2017
Q4 | $4.4M | Buy |
13,802
+465
| +3% | +$149K | 0.07% | 366 |
|
|
2017
Q3 | $4.18M | Buy |
13,337
+5,160
| +63% | +$1.53M | 0.07% | 392 |
|
|
2017
Q2 | $2.22M | Buy |
8,177
+19
| +0.2% | +$5.02K | 0.04% | 591 |
|
|
2017
Q1 | $2.23M | Sell |
8,158
-5,579
| -41% | -$1.58M | 0.04% | 592 |
|
|
2016
Q4 | $3.9M | Sell |
13,737
-5,403
| -28% | -$1.6M | 0.06% | 414 |
|
|
2016
Q3 | $5.99M | Sell |
19,140
-3,985
| -17% | -$1.18M | 0.1% | 298 |
|
|
2016
Q2 | $5.59M | Sell |
23,125
-1,494
| -6% | -$394K | 0.09% | 329 |
|
|
2016
Q1 | $6.41M | Sell |
24,619
-3,306
| -12% | -$873K | 0.11% | 273 |
|
|
2015
Q4 | $8.55M | Buy |
27,925
+1,483
| +6% | +$426K | 0.14% | 216 |
|
|
2015
Q3 | $7.72M | Buy |
26,442
+6,118
| +30% | +$2.02M | 0.12% | 234 |
|
|
2015
Q2 | $8.21M | Buy |
20,324
+2,858
| +16% | +$1.15M | 0.11% | 246 |
|
|
2015
Q1 | $7.38M | Buy |
17,466
+1,590
| +10% | +$627K | 0.1% | 263 |
|
|
2014
Q4 | $5.39M | Buy |
15,876
+743
| +5% | +$240K | 0.07% | 332 |
|
|
2014
Q3 | $5.01M | Buy |
15,133
+529
| +4% | +$174K | 0.07% | 338 |
|
|
2014
Q2 | $4.61M | Sell |
14,604
-1,239
| -8% | -$373K | 0.06% | 354 |
|
|
2014
Q1 | $4.85M | Sell |
15,843
-905
| -5% | -$287K | 0.07% | 320 |
|
|
2013
Q4 | $4.68M | Sell |
16,748
-1,199
| -7% | -$310K | 0.08% | 327 |
|
|
2013
Q3 | $4.32M | Sell |
17,947
-1,900
| -10% | -$425K | 0.08% | 324 |
|
|
2013
Q2 | $4.27M | Buy |
+19,847
| New | +$4.24M | 0.08% | 304 |
|
Other funds holding BIIB
Advisors Asset Management's BIIB Position: Q2 2026 in Review
Advisors Asset Management increased its Biogen (BIIB) stake by 107% in Q2 2026, buying an estimated $1.32M and bringing the position to 13,312 shares worth $2.88M. The position accounts for 0.04% of the portfolio, ranked #514.
Advisors Asset Management first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.55M in Q4 2015. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Advisors Asset Management held 13,312 shares of Biogen worth $2.88M as of Q2 2026.
- Advisors Asset Management bought 6,881 Biogen shares in Q2 2026, an estimated $1.32M.
- Biogen made up 0.04% of Advisors Asset Management's portfolio in Q2 2026, its #514 holding.
- Advisors Asset Management first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Advisors Asset Management's Biogen position peaked at $8.55M in Q4 2015.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.